title
On-Site COVID-19 Testing
end
DESCRIPTION: Authorization to award contract to ProPhase Labs Inc. for on-site COVID-19 testing for RTA employees and contractors
AGENDA NO: 21-138
ACTION REQUEST:
? Approval ? Review Comment ? Information Only ? Other
RECOMMENDATION:
recommendation
To authorize the Chief Executive Officer to award a contract to ProPhase Labs, Inc. for on-site COVID-19 testing for all RTA employees and contractors as outlined in the Invitation for Bids (IFB) No. 2021-020.
end
ISSUE/BACKGROUND:
body
RTA continues to implement and maintain a multi-tiered approach to mitigating the overall level of risk of illness/exposure to COVID-19 for its employees and contractors. Staff believes procurement and deployment of external on-site testing resources at each of its facilities serve to further protect the health and wellbeing of workers and their families. The Centers for Disease Control (CDC), Occupational Safety and Health Administration (OSHA), Federal Transit Administration (FTA), and American Public Transportation Association (APTA) have all endorsed regular COVID testing as a specific protective measure for transit agencies to take, combined with requiring masks, promoting/requiring vaccines among workers, and promoting physical distancing and remote work arrangements, to help curb the spread of SARS-CoV-2, the coronavirus that causes COVID-19.
end
DISCUSSION:
RTA has established a need for external COVID-19 testing to further protect employees and contractors from exposure to the SARS-CoV-2 virus which causes COVID-19. In addition to other protective measures taken by RTA management such as masks, mandated COVID-19 vaccines for its employees, and promoting physical distancing at its facilities, providing regular testing will help identify symptomatic as well as asymptomatic COVID-positive individuals before they come into contact with fellow employees, customers, and the general public throughout the system.
FINANCIAL IMPACT:
...
Click here for full text